BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38206908)

  • 21. The Effectiveness of Synbiotic Preparation Containing
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
    Andresen V; Gschossmann J; Layer P
    Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
    Airaksinen K; Yeung N; Lyra A; Lahtinen SJ; Huttunen T; Shanahan F; Ouwehand AC
    Benef Microbes; 2019 Jul; 10(6):617-627. PubMed ID: 31131616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
    Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
    Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do synbiotics really enhance beneficial synbiotics effect on defecation symptoms in healthy adults?: Randomized, double-blind, placebo-controlled trial.
    Ito D; Yamamoto Y; Maekita T; Yamagishi N; Kawashima S; Yoshikawa T; Tanioka K; Yoshida T; Iguchi M; Kunitatsu K; Kanai Y; Kato S; Kitano M
    Medicine (Baltimore); 2022 Feb; 101(8):e28858. PubMed ID: 35212286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of
    Tomita T; Fukui H; Okugawa T; Nakanishi T; Mieno M; Nakai K; Eda H; Kitayama Y; Oshima T; Shinzaki S; Miwa H
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study.
    Bekkali NL; Bongers ME; Van den Berg MM; Liem O; Benninga MA
    Nutr J; 2007 Aug; 6():17. PubMed ID: 17683583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of Bifidobacterium longum BB536 in Elderly Individuals With Chronic Constipation: A Randomized Controlled Trial.
    Takeda T; Asaoka D; Nojiri S; Yanagisawa N; Nishizaki Y; Osada T; Koido S; Nagahara A; Katsumata N; Odamaki T; Xiao JZ; Ohkusa T; Sato N
    Am J Gastroenterol; 2023 Mar; 118(3):561-568. PubMed ID: 36216361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and safety of bifidobacteria and berberine in people with hyperglycemia: study protocol for a randomized controlled trial.
    Ming J; Xu S; Liu C; Liu X; Jia A; Ji Q
    Trials; 2018 Jan; 19(1):72. PubMed ID: 29373989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomised controlled trial (NTRTC: 1571).
    Tabbers MM; Chmielewska A; Roseboom MG; Boudet C; Perrin C; Szajewska H; Benninga MA
    BMC Pediatr; 2009 Mar; 9():22. PubMed ID: 19296845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised clinical trial: efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation--a double-blind, controlled, crossover study.
    Riezzo G; Orlando A; D'Attoma B; Guerra V; Valerio F; Lavermicocca P; De Candia S; Russo F
    Aliment Pharmacol Ther; 2012 Feb; 35(4):441-50. PubMed ID: 22225544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.
    Ten Bruggencate SJ; Girard SA; Floris-Vollenbroek EG; Bhardwaj R; Tompkins TA
    Eur J Clin Nutr; 2015 Mar; 69(3):385-91. PubMed ID: 25369827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised clinical trial: Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation.
    Dimidi E; Zdanaviciene A; Christodoulides S; Taheri S; Louis P; Duncan PI; Emami N; Crabbé R; De Castro CA; McLean P; Bergonzelli GE; Whelan K; Mark Scott S
    Aliment Pharmacol Ther; 2019 Feb; 49(3):251-264. PubMed ID: 30585341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a new synbiotic supplement on symptoms, stool consistency, intestinal transit time and gut microbiota in patients with severe functional constipation: a pilot randomized double-blind, controlled trial.
    Bazzocchi G; Giovannini T; Giussani C; Brigidi P; Turroni S
    Tech Coloproctol; 2014 Oct; 18(10):945-53. PubMed ID: 25091346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B).
    Masuda H; Tanabe Y; Sakai H; Matsumoto K; Shimomura A; Doi M; Miyoshi Y; Takahashi M; Sagara Y; Tokunaga S; Iwasa T; Niikura N; Yoshimura K; Takano T; Tsurutani J
    Breast; 2023 Oct; 71():22-28. PubMed ID: 37459790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial.
    Guerra PV; Lima LN; Souza TC; Mazochi V; Penna FJ; Silva AM; Nicoli JR; Guimarães EV
    World J Gastroenterol; 2011 Sep; 17(34):3916-21. PubMed ID: 22025880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats.
    Fukui H; Oshima T; Tanaka Y; Oikawa Y; Makizaki Y; Ohno H; Tomita T; Watari J; Miwa H
    Sci Rep; 2018 Aug; 8(1):12384. PubMed ID: 30120330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probiotics (
    Dennis-Wall JC; Culpepper T; Nieves C; Rowe CC; Burns AM; Rusch CT; Federico A; Ukhanova M; Waugh S; Mai V; Christman MC; Langkamp-Henken B
    Am J Clin Nutr; 2017 Mar; 105(3):758-767. PubMed ID: 28228426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.